Dairy Products

Mulet-Cabero, Ana-Isabel; Brodkorb, André

doi:10.1007/978-3-030-56909-9_8

Cited by 3 publications

(2 citation statements)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The dairy food matrix was extensively examined in 2017 by a working group organised by the Universities of Copenhagen and Reading and its findings were published (70) . Various aspects of dairy matrix effects have been updated in more recent publications (71)(72)(73)(74) .…”

Section: Effects Of Dairy Food Matrix On Blood Lipidsmentioning

confidence: 99%

Dairy foods and cardiometabolic diseases: an update and a reassessment of the impact of SFA

Givens

2023

Proc. Nutr. Soc.

View full text Add to dashboard Cite

Type 2 diabetes (T2D) and CVD are major causes of mortality and chronic morbidity. Whilst mortality from CVD has decreased they remain the largest cause of death in Europe and the prevalence of T2D is increasing rapidly. A consistent component of public health advice is to reduce intake of SFA to reduce CVD in particular, which implies limiting dairy food consumption. The prospective studies and randomised controlled trials included in this review show that for dairy foods at least, SFA are not consistently associated with CVD or T2D risk. For CVD the association with dairy foods is generally neutral despite dairy foods being the major source of SFA in many diets. This creates considerable doubt, at least for dairy foods, concerning the validity of the traditional diet-heart hypothesis which positively relates SFA intake to increased serum LDL-cholesterol and subsequent increased CVD. There is now emerging evidence to explain this which is highly relevant to dairy foods. These include the potentially counterbalancing effect of SFA-stimulated HDL-cholesterol and specific food matrix factors. In addition, SFA are associated with the less atherogenic large buoyant LDL particles and possible counterbalancing hypotensive effects of dairy proteins. Overall, dairy foods have either a neutral or beneficial association with CVD and T2D. Beneficial associations are seen for blood pressure and the reduced T2D risk linked to yoghurt consumption, a subject that needs urgent attention given the sharp rise in T2D prevalence in many countries.

show abstract

Section: Effects Of Dairy Food Matrix On Blood Lipidsmentioning

confidence: 99%

Dairy foods and cardiometabolic diseases: an update and a reassessment of the impact of SFA

Givens

2023

Proc. Nutr. Soc.

View full text Add to dashboard Cite

show abstract

“…Various aspects of understanding dairy matrix effects have been updated in more recent publications (e.g. Aguilera, 2019 ; Feeney et al, 2021 ; Feeney & McKinley, 2020 ; Mulet‐Cabero & Brodkorb, 2021 ; Weaver, 2021 ).…”

Section: Dairy Consumption and Cardiovascular Diseasesmentioning

confidence: 99%

Saturated fats, dairy foods and cardiovascular health: No longer a curious paradox?

Givens

2022

Nutrition Bulletin

View full text Add to dashboard Cite

Cardiovascular diseases (CVDs) are a major cause of death and morbidity in many parts of the world, and many dietary guidelines limit the intake of saturated fatty acids (SFA) as they are regarded as an important risk factor for CVDs due to their association with increased blood cholesterol. Dairy foods are often a major contributor to dietary intake of SFA, and since many dietary guidelines contain restrictions on SFA intake, this can lead to a moderation of dairy food intake despite meta‐analyses generally showing dairy to have a neutral or negative association with CVDs. Many prospective studies and randomised controlled trials do not support a simple positive association between SFA intake and the risk of atherosclerotic CVD and its components although some early studies had a number of methodological weakness. Studies that included blood cholesterol data do broadly support the positive relationship between SFA and blood low‐density lipoprotein cholesterol (LDL‐C) but without increased CVD risk resulting, despite LDL being a causal factor in atherosclerotic CVD. These data suggest that LDL‐C alone is not a consistently good predictor or cause of CVD risk, perhaps particularly in relation to dairy food consumption although some non‐dairy food studies have also shown LDL‐C reduction was not reflected in reduced CVD risk. This narrative review examines some reasons for these findings. Overall, restrictions on dairy food intake do not seem warranted, although there remains a need to further understand the association of different dairy food types with chronic diseases, perhaps particularly for type 2 diabetes.

show abstract

Comparison of the impact of saturated fat from full-fat yogurt or low-fat yogurt and butter on cardiometabolic factors: a randomized cross-over trial

Ranjbar,

Nasrollahzadeh

2024

Eur J Nutr

View full text Add to dashboard Cite

Dairy Products

Cited by 3 publications

References 58 publications

Dairy foods and cardiometabolic diseases: an update and a reassessment of the impact of SFA

Dairy foods and cardiometabolic diseases: an update and a reassessment of the impact of SFA

Saturated fats, dairy foods and cardiovascular health: No longer a curious paradox?

Comparison of the impact of saturated fat from full-fat yogurt or low-fat yogurt and butter on cardiometabolic factors: a randomized cross-over trial

Contact Info

Product

Resources

About